Clinical trial
Concentration-Controlled Antiretroviral Therapy in Persons Experiencing Persistent Viremia
NCT00059384 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Concentration-Controlled Antiretroviral Therapy in Persons Experiencing Persistent Viremia
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- December 31, 2007
- Enrollment
- 66
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.